Joseph M. Coney, MD, FACS, FASRS - Eye on Equity: A Comprehensive Approach to DR/DME Care in Under-Represented Populations

About this episode

The episode discusses a comprehensive approach to diabetic retinopathy and diabetic macular edema care in under-represented populations.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/COPE/IPCE information, and to apply for credit, please visit us at PeerView.com/SYS865. CME/COPE/IPCE credit will be available until June 29, 2026. Eye on Equity: A Comprehensive Approach to DR/DME Care in Under-Represented Populations In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported by an educational grant from Genentech, a member of the Roche Group. Disclosure information is available at the beginning of the video presentation.

People in this episode

Guest: Joseph M. Coney, MD, FACS, FASRS

Topics covered

• Diabetic Retinopathy
• Diabetic Macular Edema
• Healthcare Equity
• Under-Represented Populations
• Continuing Medical Education

Keywords

• diabetic retinopathy
• diabetic macular edema
• healthcare equity
• continuing education
• under-represented populations

Sponsors

Genentech

Mentioned in this episode

Organizations: PeerView Institute for Medical Education, Accreditation Council for Continuing Medical Education, Accreditation Council for Pharmacy Education, American Nurses Credentialing Center, Roche Group

More episodes of PeerView Endocrinology & Diabetes CME/CNE/CPE Video Podcast

• Athena Philis-Tsimikas, MD - Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes (Updates From Las Vegas) · May 25, 2026 · 1h 9m
• Christina Y. Weng, MD, MBA - Reimagining Retinal Treatment: The Promise of Novel Delivery Mechanisms for Anti-VEGF Therapies · May 12, 2026 · 36 min
• Jay H. Shubrook, DO, FAAFP, FACOFP - Unlocking the Potential of Incretin-Based Therapies in T2D: Comprehensive Primary Care Strategies for Cardiometabolic Health · May 7, 2026 · 1h 25m
• Prof. Chantal Mathieu, MD, PhD - Betting on Basal Insulin: Improving the Odds for People With Type 2 Diabetes · April 3, 2026 · 1h 7m
• Peter A. Campochiaro, MD / Diana V. Do, MD - Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing · March 24, 2026 · 57 min
• John B. Buse, MD, PhD / Pam R. Taub, MD, FACC, FASPC - To Glycemia and Beyond: Managing Cardiovascular Risk in People With Type 2 Diabetes Using Incretin-Based Therapies · November 20, 2025 · 1h 4m